Genetically Proxied IL-6 Receptor Inhibition and Coronary Artery Disease Risk in a Japanese Population

被引：1
|
作者：
Zhao, Sizheng Steven [1 ]
Gill, Dipender [2 ]
机构：
[1] Univ Manchester, Fac Biol Med & Hlth, Ctr Musculoskeletal Res, Manchester Acad Hlth Sci Ctr,Div Musculoskeletal &, Oxford Rd, Manchester M13 9LJ, England
[2] Imperial Coll London, Dept Epidemiol & Biostat, London, England
来源：
CLINICAL THERAPEUTICS | 2024年 / 46卷 / 08期
关键词：
Coronary artery disease; Human genetics; IL-6; receptor; Mendelian randomization; Tocilizumab;
D O I：
10.1016/j.clinthera.2024.04.015
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：657 / 658
页数：2
相关论文
共 50 条
  • [31] The HLA system and coronary artery disease in the Japanese population
    Rauchhaus, M
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2000, 73 (03) : 281 - 282
  • [32] No association of IL-6 gene polymorphism (474 G/C) with premature coronary artery disease
    Sekuri, C
    Cam, FS
    Tengiz, I
    Sagcan, A
    Ercan, E
    Akin, M
    Berdeli, A
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 89 - 89
  • [33] Sleep Disturbances and IL-6 Receptor Inhibition in Rheumatoid Arthritis
    Fragiadaki, K.
    Tektonidou, M. G.
    Konsta, M.
    Chrousos, G. P.
    Sfikakis, P. P.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S468 - S468
  • [34] Synergistic effects of the polymorphisms in the PAI-1 and IL-6 genes with smoking in determining their associated risk with coronary artery disease
    Sarecka, Beata
    Zak, Iwona
    Krauze, Jolanta
    CLINICAL BIOCHEMISTRY, 2008, 41 (7-8) : 467 - 473
  • [35] EFFECTS OF IL-6 RECEPTOR INHIBITION THERAPY ON THE SERUM LEVELS OF IL-33 AND IL-6 IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Choi, I. A.
    Lee, S. J.
    Park, W.
    Park, S. H.
    Shim, S. -C.
    Baek, H. J.
    Yoo, D. -H.
    Kim, H. A.
    Lee, S. K.
    Lee, Y. J.
    Park, Y. E.
    Cha, H. -S.
    Lee, E. Y.
    Lee, E. B.
    Song, Y. W.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 456 - 456
  • [36] Genetic IL-6 Signaling Modifies Incident Coronary Artery Disease Risk in Chronic Kidney Disease (vol 79, pg 415, 2022)
    Yu, Z.
    Zekavat, S. M.
    Honigberg, M. C.
    Natarajan, P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (06)
  • [37] Risk of coronary artery disease in celiac disease population
    Gajulapalli, Rama D.
    Pattanshetty, Deepak J.
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2017, 23 (04): : 253 - 258
  • [38] Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease
    Salvi, M
    Girasole, G
    Pedrazzoni, M
    Passeri, M
    Giuliani, N
    Minelli, R
    Braverman, LE
    Roti, E
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (08): : 2976 - 2979
  • [39] Associations between IL-6 and Echo-Parameters in Patients with Early Onset Coronary Artery Disease
    Pauli, Natalia
    Puchalowicz, Kamila
    Kuligowska, Agnieszka
    Krzystolik, Andrzej
    Dziedziejko, Violetta
    Safranow, Krzysztof
    Rac, Michal
    Chlubek, Dariusz
    Ewa Rac, Monika
    DIAGNOSTICS, 2019, 9 (04)
  • [40] Role of IL-6 polymorphism on the development of cardiovascular events and coronary artery disease in patients receiving hemodialysis
    Song, Y.
    Gu, H. D.
    He, Y.
    Wang, J. W.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (01) : 2631 - 2637
12345